Skip to main content

Table 2 Outcomes

From: Laparoscopic versus robotic-assisted sacrocolpopexy for pelvic organ prolapse: a systematic review

Outcome

Paraiso 2011

Anger 2014

 

LSC (n = 33)

RASC (n = 35)

Mean difference

P

LSC (n = 38)

RASC (n = 40)

P

Time—sacrocolpopexy

162 ± 47 min

227 ± 47 min

67 (CI 43–89)

<.001

178.4 ± 49.8 min

202.8 ± 46.1 min

.030

Time—total operation operating

199 ± 46 min

265 ± 50 min

66 (43–90)

<.001

225.5 ± 62.3 min

246.5 ± 51.3 min

.110

Costs

- Day of surgery

- Excluding robotics

°

US$14,342 ± 2941

°

US$16,278 ± 3326

°

US$1936 (448–2,885)

°

.008

US$11,573 ± 3191

US$11,573 ± 3191

US$19,616 ± 3135

US$12,586 ± 3315

<.001

.160

Costs

- At 6 weeks

- Excluding robotics

°

°

°

°

°

°

°

°

US$12,170 ± 4129

US$12,170 ± 4129

US$20,898 ± 3386

US$13,867 ± 3386

<.001

.060

Pain

- Use of NSAIDs (days)

- VAS at nl activity(wk1)

- Activity scales (1 wk)

11 daysa

28 (2–67)

20 daysa

28 (4–68)

 

<.005a

.41

°

2.6 ± 2.2

38.1 ± 15.5

°

3.5 ± 2.1

45.4 ± 16.1

°

.044

.039

  1. LSC laparoscopic sacrocolpopexy, RASC robotic-assisted sacrocolpopexy, NSAIDs nonsteroidal anti-inflammatory drugs, VAS visual analog scale, no data available, Excluding robotics excluding costs of purchase and maintenance costs for robot
  2. aOnly visual scale (no raw data)